Arrowhead Total Liab vs Total Assets Analysis

0HI3 Stock   26.30  4.45  20.37%   
Arrowhead Pharmaceuticals financial indicator trend analysis is way more than just evaluating Arrowhead Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arrowhead Pharmaceuticals is a good investment. Please check the relationship between Arrowhead Pharmaceuticals Total Liab and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.

Total Liab vs Total Assets

Total Liab vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arrowhead Pharmaceuticals Total Liab account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Arrowhead Pharmaceuticals' Total Liab and Total Assets is 0.92. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Assets in the same time period over historical financial statements of Arrowhead Pharmaceuticals Corp, assuming nothing else is changed. The correlation between historical values of Arrowhead Pharmaceuticals' Total Liab and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Arrowhead Pharmaceuticals Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Liab i.e., Arrowhead Pharmaceuticals' Total Liab and Total Assets go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Total Assets

Total assets refers to the total amount of Arrowhead Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Arrowhead Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Arrowhead Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arrowhead Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.Selling General Administrative is likely to drop to about 79.1 M in 2024. Tax Provision is likely to drop to 1,710 in 2024
 2021 2022 2023 2024 (projected)
Gross Profit232.8M240.7M276.8M290.7M
Total Revenue243.2M240.7M276.8M290.7M

Arrowhead Pharmaceuticals fundamental ratios Correlations

0.90.870.910.780.870.04-0.920.790.660.990.250.990.40.87-0.730.850.970.920.990.810.260.360.870.50.97
0.90.870.760.50.990.38-0.880.90.380.910.230.870.10.72-0.920.870.90.950.870.860.240.020.940.440.95
0.870.870.690.450.810.27-0.870.610.390.890.640.850.180.74-0.880.980.880.950.850.650.650.280.960.420.92
0.910.760.690.750.74-0.16-0.810.720.740.90.10.910.590.82-0.550.690.860.820.910.850.110.560.720.440.81
0.780.50.450.750.49-0.4-0.630.540.80.72-0.150.810.470.78-0.190.390.750.480.810.53-0.140.390.380.450.66
0.870.990.810.740.490.42-0.860.940.330.890.120.830.080.7-0.90.810.880.910.840.830.13-0.070.90.450.93
0.040.380.27-0.16-0.40.42-0.170.32-0.710.140.14-0.07-0.29-0.16-0.550.260.080.29-0.060.020.12-0.620.39-0.080.27
-0.92-0.88-0.87-0.81-0.63-0.86-0.17-0.78-0.51-0.91-0.28-0.9-0.26-0.910.8-0.86-0.96-0.9-0.9-0.75-0.3-0.23-0.87-0.58-0.93
0.790.90.610.720.540.940.32-0.780.360.79-0.170.760.070.66-0.740.630.80.760.770.81-0.16-0.170.730.460.83
0.660.380.390.740.80.33-0.71-0.510.360.560.050.730.390.71-0.140.410.610.440.730.610.060.630.330.430.46
0.990.910.890.90.720.890.14-0.910.790.560.270.960.430.83-0.770.860.960.940.970.780.280.330.90.460.98
0.250.230.640.1-0.150.120.14-0.28-0.170.050.270.250.00.2-0.470.640.260.460.230.071.00.410.530.040.3
0.990.870.850.910.810.83-0.07-0.90.760.730.960.250.360.9-0.70.830.970.891.00.820.260.380.840.520.94
0.40.10.180.590.470.08-0.29-0.260.070.390.430.00.360.270.070.110.290.280.370.150.010.70.180.120.27
0.870.720.740.820.780.7-0.16-0.910.660.710.830.20.90.27-0.550.730.940.750.890.710.210.380.680.640.82
-0.73-0.92-0.88-0.55-0.19-0.9-0.550.8-0.74-0.14-0.77-0.47-0.70.07-0.55-0.9-0.75-0.91-0.69-0.7-0.480.07-0.95-0.31-0.84
0.850.870.980.690.390.810.26-0.860.630.410.860.640.830.110.73-0.90.860.950.830.710.650.270.960.410.89
0.970.90.880.860.750.880.08-0.960.80.610.960.260.970.290.94-0.750.860.910.970.780.270.280.870.590.97
0.920.950.950.820.480.910.29-0.90.760.440.940.460.890.280.75-0.910.950.910.890.80.460.270.990.420.95
0.990.870.850.910.810.84-0.06-0.90.770.730.970.231.00.370.89-0.690.830.970.890.820.240.380.830.520.94
0.810.860.650.850.530.830.02-0.750.810.610.780.070.820.150.71-0.70.710.780.80.820.080.260.740.390.76
0.260.240.650.11-0.140.130.12-0.3-0.160.060.281.00.260.010.21-0.480.650.270.460.240.080.420.530.030.31
0.360.020.280.560.39-0.07-0.62-0.23-0.170.630.330.410.380.70.380.070.270.280.270.380.260.420.180.060.18
0.870.940.960.720.380.90.39-0.870.730.330.90.530.840.180.68-0.950.960.870.990.830.740.530.180.390.93
0.50.440.420.440.450.45-0.08-0.580.460.430.460.040.520.120.64-0.310.410.590.420.520.390.030.060.390.47
0.970.950.920.810.660.930.27-0.930.830.460.980.30.940.270.82-0.840.890.970.950.940.760.310.180.930.47
Click cells to compare fundamentals

Arrowhead Pharmaceuticals Account Relationship Matchups

Arrowhead Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets522.5M710.1M691.9M765.6M880.4M924.4M
Other Current Liab32.8M33.3M100.4M58.2M66.9M70.2M
Total Current Liabilities40.7M146.5M74.1M105.5M121.3M127.3M
Total Stockholder Equity461.8M408.8M106.0M271.3M312.0M327.6M
Property Plant And Equipment Net47.0M66.0M168.6M335.6M385.9M405.2M
Net Debt(122.4M)(158.9M)(26.4M)4.3M3.9M4.0M
Retained Earnings(503.8M)(644.7M)(820.8M)(1.0B)(923.4M)(877.3M)
Accounts Payable6.8M9.5M2.9M35.9M41.2M43.3M
Cash143.6M184.4M108.0M110.9M127.5M133.9M
Non Current Assets Total200.1M325.6M315.5M346.0M397.9M417.8M
Non Currrent Assets Other265.4K272K29.1M210K241.5K229.4K
Cash And Short Term Investments315.5M367.8M376.4M403.6M464.2M487.4M
Net Receivables661.4K845.7K10.3M1.4M1.6M970.9K
Common Stock Shares Outstanding100.7M103.7M105.4M106.8M122.8M128.9M
Liabilities And Stockholders Equity522.5M710.1M691.9M765.6M880.4M924.4M
Inventory3.3M4.3M4.4M(21.6M)(19.5M)(18.5M)
Other Current Assets6.0M6.6M27.5M15.9M18.3M19.2M
Other Stockholder Equity965.4M1.1B1.2B1.3B1.5B1.6B
Total Liab60.7M301.3M586.0M478.4M550.1M577.7M
Total Current Assets322.4M384.6M376.4M419.5M482.4M506.6M
Accumulated Other Comprehensive Income18.4K(69K)(136K)(3.2M)(2.9M)(2.8M)
Short Term Debt1.1M4.5M5.6M10.6M12.1M12.8M
Common Stock194.7K197K106.0M200K230K218.5K
Current Deferred Revenue19.3M111.1M74.1M866K995.9K946.1K
Non Current Liabilities Total20.0M154.8M511.9M372.9M428.9M450.3M
Short Term Investments171.9M183.4M268.4M292.7M336.6M353.5M
Intangible Assets15.4M13.7M12.0M10.3M11.8M10.2M
Other Liab1.9M8.7M131.5M56.0M64.3M44.0M
Net Tangible Assets446.4M395.2M386.6M261.1M300.2M291.5M
Capital Surpluse582.9M664.1M965.4M1.1B1.2B831.6M
Property Plant Equipment47.0M66.0M168.6M335.6M385.9M405.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Arrowhead Stock Analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.